Combined use of 111In-DTPA-D-Phe-1-octreotide (OCT) and 123I-vasoactive intestinal peptide (VIP) in the localization diagnosis of medullary thyroid carcinoma (MTC)

Nuclear Medicine and Biology

Volumn 23, Issue 4, 1996, Pages 503-507

  Kurtaran, Amir ^a   Leimer, Maria ^a   Kaserer, Klaus ^a   Yang, Qiong ^a   Angelberger, Peter ^b   Niederle, Bruno ^a   Virgolini, Irene ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b ARC SEIBERSDORF RESEARCH GMBH   (Austria)

Author keywords

111In DTPA D Phe 1 octreotide; 123I vasoactive intestinal peptide; In vitro studies; In vivo studies; Medullary thyroid carcinoma

Indexed keywords

PENTETATE INDIUM IN 111; PENTETREOTIDE; PENTETREOTIDE IN 111; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL PEPTIDE I 123; VASOACTIVE INTESTINAL POLYPEPTIDE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDIUM; OCTREOTIDE; PENTETIC ACID; RADIOACTIVE IODINE; SDZ 215 811; SDZ 215-811; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THYROID MEDULLARY CARCINOMA; CLINICAL TRIAL; MEDULLARY CARCINOMA; METABOLISM; MIDDLE AGED; THYROID TUMOR;

ADULT; AGED; CARCINOMA, MEDULLARY; FEMALE; HUMANS; INDIUM RADIOISOTOPES; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; OCTREOTIDE; PENTETIC ACID; RECEPTORS, SOMATOSTATIN; THYROID NEOPLASMS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0030131581     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(96)00031-5     Document Type: Article

References (37)

1. 1. Abdelmoumene N., Schlumberger M., Gardet P., Roche A., Travagli J. P., Francese C. and Parmentier C. (1994) Selective venous sampling catheterisation for localization of persisting medullary thyroid carcinoma. Br. J. Cancer. 69, 1141-1144.
2. 2. Anderson R. J., Sizemore G. W., Wahner H. W. and Carney J. A. (1978) Thyroid scintigraphy in familial medullary carcinoma of the thyroid gland. Clin. Nucl. Med. 3, 147-151.
3. 111In-DTPA-D-Phe-1-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: Synthesis, radiolabeling and in vitro validation. Life Sci. 49, 1583-1591.
4. 99mTc-MDP - An evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. J. Nucl. Med. 29, 33-38.
5. 131I-MIBG and medullary carcinoma of the thyroid. Lancet 2, 1273-1274.
6. 6. Couvineau A., Rouyer F. C., Darmoul D., Maoret J. J., Carrero I., Ogier-Denis E. and Laburthe M. (1994) Human intestinal VIP receptor: Cloning and functional expression of two DNA encoding proteins with different N-terminal domains. Biochem. Biophys. Res. Commun. 200, 769-776.
7. 7. Dorr U., Frank-Raue K., Sautter-Bihl M. L., Guzman G., Buhr H. J. and Bihl H. (1993) The potential value of somatostatin receptor scintigraphy in medullary thyroid carcinoma. Nucl. Med. Commun. 14, 439-445.
8. 131I-MIBG. Lancet 2, 233.
9. 9. Frank-Raue K., Raue F., Buhr H. J., Baldauf G., Lorenz D. and Ziegler R. (1992) Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: High sensitivity of selective venous catheterization. Thyroid 2, 113-117.
10. 10. Hazard J. B., Hawk W. A. and Crile G. Jr. (1995) Medullary carcinoma of the thyroid - a clinicopathological entity. J. Clin. Endocrinol. Metab. 19, 152-161.
11. 11. Hoefnagel C. A., Delprat C. C., Zanin D. and Schoot J. B. (1988) New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma. Clin. Nucl. Med. 13, 159-165.
12. 12. Jensen M. H., Davis R. K. and Derrick L. (1990) Thyroid cancer: A computer-assisted review of 5287 cases. Otolaryngol. Head Neck Surg. 102, 51-65.
13. 111In-octreotide scintigraphy in oncology. Digestion 54, 84-87.
14. 111In-octreotide scintigraphy. Eur. J. Nucl. Med. 19, 559 (A).
15. 15. Kwekkeboom D. J., Reubi J. C., Lamberts S. W. J. Bruining H. A., Mulder A. H., Oei H. Y. and Krenning E. P. (1993) In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 76, 1413-1417.
16. 16. Lamberts S. W. J., Krenning E. P. and Reubi J. C. (1991) The role of somatostatin and its analogs on the diagnosis and treatment of tumors. Endocr. Rev. 12, 450-482.
17. 17. Lebouthiller G., Morais J., Picard M., Picard D., Chartrand R. and D'Amour P. (1993) Tc-99m-Sestamibi and other agents in the detection of metastatic medullary carcinoma of the thyroid. Clin. Nucl. Med. 18, 657-661.
18. 111In-pentetreotide in the detection of malignancies. In Radioactive Isotopes in Clinical Medicine and Research (Edited by Hoefer R. and Bergmann H.), pp. 387-391.
19. 111In-labeled anti-CEA monoclonal antibody fragments. Nucl. Med. Commun. 13, 142-148.
20. 20. O'Driscoll C. M., Baker F., Casey M. J. and Duffy D. J. (1991) Localization of recurrent medullary carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: A case report. J. Nucl. Med. 322, 281-283.
21. 21. Ohta H., Yamamota K., Endo K., Mori T., Hamanaka D., Shimazu A., Ikekubo K., Makimoto K., Iida Y. and Konishi J. (1984). A new imaging agent for medullary carcinoma of the thyroid. J. Nucl. Med. 25, 323-325.
22. 22. Parthasarathy K. L., Shirmaoka K., Bakshi S. P. and Razack M. S. (1980) Radiotracer uptake in medullary carcinoma of the thyroid. Clin. Nucl. Med. 5, 45-48.
23. 23. Reubi J. C., Chayvialle J. A., Franc B., Cohen R., Calmettes C. and Modigliani E. (1991) Somatostatin receptors and somatostatin content in medullary thyroid carcinomas. Lab. Invest. 64, 567-573.
24. 24. Rohrer L., Raulf F., Bruns C., Buetter R., Hofstaedter F. and Schüler R. (1993) Cloning and characterization of fourth human somatostatin receptor. Proc. Natl. Acad. Sci. USA 90, 4196-4200.
25. 25. Rougier P., Calmettes C., Laplanche A., Travagli J. P., Lefevre M., Parmantier C., Milhaud G. and Tubiana M. (1983) The values of thyroid calcitonin and carcinoembryonic antigen in the treatment and management of nonfamilial medullary thyroid carcinoma. Cancer 51, 855-862.
26. 26. Saad M. F., Ordonez N. G., Rashid R. K., Guido J. J., Hill Jr. C. S., Hickey R. C. and Samaan N. A. (1984) Medullary carcinoma of the thyroid. Medicine 63, 319-342.
27. 27. Sano T., Kagawa N., Hizawa K., Saito H. and Saito S. (1980). Demonstration of somatostatin production in medullary carcinoma of the thyroid. Jpn. Oncol. 10, 221.
28. 28. Senga O., Miyakawa M., Shirota H., Kobayashi S., Sugenoya A., Ivasa T., Makiuchi M., Yano K., Miyazawa M. and Takizawa M. (1982) Comparison of TI-201-chloride and Ga-67-citrate scintigraphy in the diagnosis of thyroid tumour: Concise communication. J. Nucl. Med. 23, 225-228.
29. 29. Sreedharan S. P., Robichon A., Petrson K. E. and Goetzl E. J. (1991) Cloning and expression of the human vasoactive intestinal peptide receptor. Proc. Natl. Acad. Sci. USA 88, 4986-4990.
30. 30. Svoboda M., Tastenoy M., Van-Rampelberg J., Goossens J. F., De-Neef P., Waelbroeck M. and Robberecht P. (1994) Molecular cloning and functional characterization of a human VIP receptor from sup-T1 lymphoblasts. Biochem. Biophys. Res. Commun. 205, 1617-1624.
31. 31. Udelsman R., Ball D., Baylin S. B., Wong C. Y., Osterman F. A. Jr. and Sostre S. (1993) Preoperative localization of occult medullary carcinoma of the thyroid gland with single photon emission tomography dimercaptosuccinic acid. Surgery 114, 1083-1089.
32. 32. Virgolini I., Kurtaran A., Raderet M., Leimer M., Angelberger P., Havlik E., Li S., Scheithauer W., Niederle B., Valent P. and Eichler H. G. (1995) Vasoactive intestinal peptide receptor scintigraphy. J. Nucl. Med. 36, 1732-1739.
33. 33. Virgolini I., Raderer M., Kurtaran A., Angelberger P., Banyai S., Yang Q., Li S., Banyai M., Pidlich J., Niederle B., Scheithauer W. and Valent P. (1994a) Vasoactive intestinal peptide-receptor imaging for the localization of intestinal adenocarcinomas and endocrine tumors. N. Engl. J. Med. 331, 1116-1121.
34. 34. Virgolini I., Yang Q., Li S., Angelberger P., Neuhold N., Niederle B., Scheithauer W. and Valent P. (1994b) Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors. Cancer Res. 54, 690-700.
35. 2 fragments of anticarcino-embryonic antigen monoclonal antibody for detecting recurrences of medullary thyroid carcinoma. J. Clin. Endocrinol. Metab. 74, 157-163.
36. 36. Wells S. A., Dilley W. G., Farndon J. A., Leight G. S. and Baylin S. B. (1985) Early diagnosis and treatment of medullary carcinoma. Arch. Intern. Med. 145, 1248-1252.
37. 37. Yamada Y., Post S. R., Wang K., Tager H. S., Bell G. I. and Seino S. (1992) Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidneys. Proc. Natl. Acad. Sci. USA 89, 251-255.